Evidence of SARS-CoV-2 Transmission Through the Ocular Route

References

• Novel Coronavirus (2019-nCoV) situation report – 22. World Health Organization (WHO). Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200211-sitrep-22-ncov.pdf?sfvrsn=fb6d49b1_2. Accessed February 11, 2020.
   Google Scholar
• Gorbalenya AE, Baker SC, Baric RS, et al. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;5(4):536–544.
   PubMed Web of Science ®Google Scholar
• WHO Director-General’s opening remarks at the media briefing on COVID-19-11 March 2020. World Health Organization (WHO). Available from: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19—11-march-2020. Accessed March 11, 2020.
   Google Scholar
• Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270–273. doi:10.1038/s41586-020-2012-7
   PubMed Web of Science ®Google Scholar
• Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet (London, England). 2020;395(10224):565–574. doi:10.1016/S0140-6736(20)30251-8
   PubMed Web of Science ®Google Scholar
• Chan JF, Kok KH, Zhu Z, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020;9(1):221–236. doi:10.1080/22221751.2020.1719902
   PubMed Web of Science ®Google Scholar
• Jin Y, Yang H, Ji W, et al. Virology, epidemiology, pathogenesis, and control of COVID-19. Viruses. 2020;12(4):372. doi:10.3390/v12040372
   PubMed Web of Science ®Google Scholar
• Hossain MG, Javed A, Akter S, Saha S. SARS-CoV-2 host diversity: an update of natural infections and experimental evidence. J Microbiol Immunol Infect. 2020. doi:10.1016/j.jmii.2020.06.006
   Google Scholar
• The Chinese Center for Disease Control and Prevention isolated the new coronavirus from the outer packaging of cold chain food. Chinese Center for Disease Control and Prevention (CDC). Available from: http://www.chinacdc.cn/yw_9324/202010/t20201017_222144.html. Accessed October 17, 2020.
   Google Scholar
• Tsatsakis A, Calina D, Falzone L, et al. SARS-CoV-2 pathophysiology and its clinical implications: an integrative overview of the pharmacotherapeutic management of COVID-19. Food Chem Toxicol. 2020;146:111769. doi:10.1016/j.fct.2020.111769
   PubMed Web of Science ®Google Scholar
• Khalili M, Chegeni M, Javadi S, Farokhnia M, Sharifi H, Karamouzian M. Therapeutic interventions for COVID-19: a living overview of reviews. Ther Adv Respir Dis. 2020;14:1753466620976021. doi:10.1177/1753466620976021
   Web of Science ®Google Scholar
• WHO Coronavirus disease (COVID-19) dashboard. World Health Organization (WHO). Available from: https://covid19.who.int/. Accessed January 8, 2021.
   Google Scholar
• China’s new coronavirus vaccine is approved for marketing! The State Council of the People’s Republic of China. Available from: http://www.gov.cn/xinwen/2020-12/31/content_5575757.htm. Accessed December 31, 2020.
   Google Scholar
• FDA takes key action in fight against COVID-19 by issuing emergency use authorization for first COVID-19 vaccine. The U.S. Food and Drug Administration. Available from: https://www.fda.gov/news-events/press-announcements/fda-takes-key-action-fight-against-covid-19-issuing-emergency-use-authorization-first-covid-19. Accessed December 11, 2020.
   Google Scholar
• Lu CW, Liu XF, Jia ZF. 2019-nCoV transmission through the ocular surface must not be ignored. Lancet (London, England). 2020;395(10224):e39. doi:10.1016/S0140-6736(20)30313-5
   PubMed Web of Science ®Google Scholar
• Casalino G, Monaco G, Di Sarro PP, David A, Scialdone A. Coronavirus disease 2019 presenting with conjunctivitis as the first symptom. Eye (London, England). 2020;34(7):1235–1236. doi:10.1038/s41433-020-0909-x
   PubMed Web of Science ®Google Scholar
• Chavis A, Bakken H, Ellenby M, Hasan R. COVID-19 and telehealth: prevention of exposure in a medically complex patient with a mild presentation. Article in press. J Adolesc Health. 2020;67(3):456–458. doi:10.1016/j.jadohealth.2020.06.001
   Web of Science ®Google Scholar
• Hui KP, Peiris M, Nicholls JM, Chan MC. SARS-CoV-2 infection in conjunctival tissue - authors’ reply. Lancet Respir Med. 2020;8(7):e58. doi:10.1016/S2213-2600(20)30273-3
   Web of Science ®Google Scholar
• Liu YC, Ang M, Ong HS, Wong TY, Mehta JS. SARS-CoV-2 infection in conjunctival tissue. Lancet Respir Med. 2020;8(7):e57. doi:10.1016/S2213-2600(20)30272-1
   Web of Science ®Google Scholar
• Machhi J, Herskovitz J, Senan AM, et al. The natural history, pathobiology, and clinical manifestations of SARS-CoV-2 infections. J Neuroimmune Pharmacol. 2020;15:1–28. doi:10.1007/s11481-019-09901-x
   PubMed Web of Science ®Google Scholar
• Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271–280 e8. doi:10.1016/j.cell.2020.02.052
   PubMed Web of Science ®Google Scholar
• Sungnak W, Huang N, Becavin C, et al. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Article. Nat Med. 2020;26(5):681–687. doi:10.1038/s41591-020-0868-6
   PubMed Web of Science ®Google Scholar
• Zhou L, Xu Z, Castiglione GM, Soiberman US, Eberhart CG, Duh EJ. ACE2 and TMPRSS2 are expressed on the human ocular surface, suggesting susceptibility to SARS-CoV-2 infection. Ocul Surf. 2020;18(4):537–544. doi:10.1016/j.jtos.2020.06.007
   PubMed Web of Science ®Google Scholar
• Roehrich H, Yuan C, Hou JH. Immunohistochemical study of SARS-CoV-2 viral entry factors in the cornea and ocular surface. Cornea. 2020;39(12):1556–1562. doi:10.1097/ICO.0000000000002509
   PubMed Web of Science ®Google Scholar
• Li S, Li D, Fang J, et al. SARS-CoV-2 receptor ACE2 is expressed in human conjunctival tissue, especially in diseased conjunctival tissue. Ocul Surf. 2020. doi:10.1016/j.jtos.2020.09.010
   Web of Science ®Google Scholar
• Holappa M, Vapaatalo H, Vaajanen A. Many faces of renin-angiotensin system – focus on eye. Open Ophthalmol J. 2017;11:122–142. doi:10.2174/1874364101711010122
   PubMed Web of Science ®Google Scholar
• Senanayake P, Drazba J, Shadrach K, et al. Angiotensin II and its receptor subtypes in the human retina. Invest Ophthalmol Vis Sci. 2007;48(7):3301–3311. doi:10.1167/iovs.06-1024
   PubMed Web of Science ®Google Scholar
• Luhtala S, Vaajanen A, Oksala O, Valjakka J, Vapaatalo H. Activities of angiotensin-converting enzymes ACE1 and ACE2 and inhibition by bioactive peptides in porcine ocular tissues. J Ocular Pharmacol Therap. 2009;25(1):23–28. doi:10.1089/jop.2008.0081
   PubMed Web of Science ®Google Scholar
• Cavalleri M, Brambati M, Starace V, et al. Ocular features and associated systemic findings in SARS-CoV-2 infection. Ocul Immunol Inflamm. 2020;28(6):916–921. doi:10.1080/09273948.2020.1781198
   PubMed Web of Science ®Google Scholar
• Ordas CM, Villacieros-Alvarez J, Pastor-Vivas AI, Corrales-Benitez A. Concurrent tonic pupil and trochlear nerve palsy in COVID-19. J Neurovirol. 2020;26:970–972. doi:10.1007/s13365-020-00909-1
   Web of Science ®Google Scholar
• Otaif W, Al Somali AI, Al Habash A. Episcleritis as a possible presenting sign of the novel coronavirus disease: a case report. Am J Ophthalmol. 2020;20:100917. doi:10.1016/j.ajoc.2020.100917
   Google Scholar
• Invernizzi A, Pellegrini M, Messenio D, et al. Impending central retinal vein occlusion in a patient with Coronavirus disease 2019 (COVID-19). Ocul Immunol Inflamm. 2020;28(8):1290–1292. doi:10.1080/09273948.2020.1807023
   PubMed Web of Science ®Google Scholar
• Benito-Pascual B, Gegundez JA, Diaz-Valle D, et al. Panuveitis and optic neuritis as a possible initial presentation of the novel Coronavirus disease 2019 (COVID-19). Ocul Immunol Inflamm. 2020;28(6):922–925. doi:10.1080/09273948.2020.1792512
   PubMed Web of Science ®Google Scholar
• Tisdale AK, Chwalisz B. Neuro-ophthalmic manifestations of coronavirus disease 19. Curr Opin Ophthalmol. 2020;Publish Ahead of Print. doi:10.1097/ICU.0000000000000707
   Web of Science ®Google Scholar
• Li X, Wang M, Dai J, Wang W, Yang Y, Jin W. Novel coronavirus disease with conjunctivitis and conjunctivitis as first symptom: two cases report. Zhonghua Shiyan Yanke Zazhi. 2020;38(4):318–321.
   Google Scholar
• Zhang X, Chen X, Chen L, et al. The evidence of SARS-CoV-2 infection on ocular surface. Ocul Surf. 2020;18(3):360–362. doi:10.1016/j.jtos.2020.03.010
   PubMed Web of Science ®Google Scholar
• Ying NY, Idris NS, Muhamad R, Ahmad I. Coronavirus disease 2019 presenting as conjunctivitis. Korean J Fam Med. 2020. doi:10.4082/kjfm.20.0090
   Web of Science ®Google Scholar
• Daruich A, Martin D, Bremond-Gignac D. Ocular manifestation as first sign of Coronavirus disease 2019 (COVID-19): interest of telemedicine during the pandemic context. J Fr Ophtalmologie. 2020;43(5):389–391. doi:10.1016/j.jfo.2020.04.002
   PubMed Web of Science ®Google Scholar
• Cheema M, Aghazadeh H, Nazarali S, et al. Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19). Can J Ophthalmol. 2020;55(4):e125–e129. doi:10.1016/j.jcjo.2020.03.003
   PubMed Web of Science ®Google Scholar
• Salducci M, La Torre G. COVID-19 emergency in the cruise’s ship: a case report of conjunctivitis. Clin Ter. 2020;171(3):e189–e191. doi:10.7417/CT.2020.2212
   PubMed Web of Science ®Google Scholar
• Scalinci SZ, Trovato Battagliola E. Conjunctivitis can be the only presenting sign and symptom of COVID-19. IDCases. 2020;20:e00774. doi:10.1016/j.idcr.2020.e00774
   PubMed Web of Science ®Google Scholar
• Wu P, Liang L, Chen C, Nie S. A child confirmed COVID-19 with only symptoms of conjunctivitis and eyelid dermatitis. Letter. Graefe’s Arch Clin Exp Ophthalmol. 2020;258(7):1565–1566. doi:10.1007/s00417-020-04708-6
   Web of Science ®Google Scholar
• COVID-19 testing overview. Centers for Disease Control and Prevention. Available from: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/testing.html. Accessed December 7, 2020.
   Google Scholar
• Colavita F, Lapa D, Carletti F, et al. SARS-CoV-2 isolation from ocular secretions of a patient with COVID-19 in Italy with prolonged viral RNA detection. Ann Intern Med. 2020;173(3):242–243. doi:10.7326/M20-1176
   PubMed Web of Science ®Google Scholar
• Hui KPY, Cheung MC, Perera R, et al. Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures. Lancet Respir Med. 2020;8(7):687–695. doi:10.1016/S2213-2600(20)30193-4
   PubMed Web of Science ®Google Scholar
• Guo D, Xia J, Wang Y, Zhang X, Shen Y, Tong JP. Relapsing viral keratoconjunctivitis in COVID-19: a case report. Virol J. 2020;17(1):97. doi:10.1186/s12985-020-01370-6
   PubMed Web of Science ®Google Scholar
• Sindhuja K, Lomi N, Asif MI, Tandon R. Clinical profile and prevalence of conjunctivitis in mild COVID-19 patients in a tertiary care COVID-19 hospital: a retrospective cross-sectional study. Indian J Ophthalmol. 2020;68(8):1546–1550. doi:10.4103/ijo.IJO_1319_20
   PubMed Web of Science ®Google Scholar
• Chen L, Deng C, Chen X, et al. Ocular manifestations and clinical characteristics of 535 cases of COVID-19 in Wuhan, China: a cross-sectional study. Acta Ophthalmol. 2020;98. Doi:10.1111/aos.14472
   Web of Science ®Google Scholar
• Workman AD, Jafari A, Welling DB, et al. Airborne aerosol generation during endonasal procedures in the era of COVID-19: risks and recommendations. Otolaryngol. Head Neck Surg. 2020;163(3):465–470. doi:10.1177/0194599820931805
   Web of Science ®Google Scholar
• Jayaweera M, Perera H, Gunawardana B, Manatunge J. Transmission of COVID-19 virus by droplets and aerosols: a critical review on the unresolved dichotomy. Environ Res. 2020;188:109819. doi:10.1016/j.envres.2020.109819
   PubMed Web of Science ®Google Scholar
• Tang S, Mao Y, Jones RM, et al. Aerosol transmission of SARS-CoV-2? Evidence, prevention and control. Environ Int. 2020;144:106039. doi:10.1016/j.envint.2020.106039
   PubMed Web of Science ®Google Scholar
• Liyanage S, Ramasamy P, Elhaddad O, Darcy K, Hudson A, Keller J. Assessing visible aerosol generation during vitrectomy in the era of Covid-19. Eye (London, England). 2020;1–4.
   Google Scholar
• Okada M, Sousa DC, Fabinyi DCA, et al. Vitrectomy as an aerosol-generating procedure in the time of COVID-19: the VAPOR study. Ophthalmol Retina. 2020.
   Google Scholar
• Khamar P, Shetty R, Balakrishnan N, et al. Quantitative shadowgraphy of aerosol and droplet creation during oscillatory motion of the microkeratome amid COVID-19 and other infectious diseases. Article in Press. J Cataract Refract Surg. 2020;46(10):1416–1421. doi:10.1097/j.jcrs.0000000000000326
   Web of Science ®Google Scholar
• Darcy K, Elhaddad O, Achiron A, et al. Reducing visible aerosol generation during phacoemulsification in the era of Covid-19. Eye (London, England). 2020;1–6.
   Google Scholar
• McGhee CNJ, Dean S, Freundlich SEN, et al. Microdroplet and spatter contamination during phacoemulsification cataract surgery in the era of COVID −19. Clin Experiment Ophthalmol. 2020;48:1168–1174. doi:10.1111/ceo.13861
   PubMed Web of Science ®Google Scholar
• Workman AD, Welling DB, Carter BS, et al. Endonasal instrumentation and aerosolization risk in the era of COVID-19: simulation, literature review, and proposed mitigation strategies. Int Forum Allergy Rhinol. 2020;10(7):798–805. doi:10.1002/alr.22577
   PubMed Web of Science ®Google Scholar
• Chari DA, Workman AD, Chen JX, et al. Aerosol dispersion during mastoidectomy and custom mitigation strategies for otologic surgery in the COVID-19 era. Otolaryngol. Head Neck Surg. 2020;194599820941835.
   Web of Science ®Google Scholar
• Tang Y, Li C, Chen Y, et al. Effect of Intraocular Pressure on Aerosol Density Generated by Noncontact Tonometer Measurement. J Glaucoma. 2020;29(11):1001–1005. doi:10.1097/IJG.0000000000001669
   Web of Science ®Google Scholar
• Aytogan H, Ayintap E, Ozkalay Yilmaz N. Detection of Coronavirus disease 2019 viral material on environmental surfaces of an ophthalmology examination room. JAMA Ophthalmol. 2020;138(9):990–993. doi:10.1001/jamaophthalmol.2020.3154
   Web of Science ®Google Scholar
• Ong SC, Razali MAB, Shaffiee L, et al. Do slit-lamp shields and face masks protect ophthalmologists amidst COVID-19? Ophthalmology. 2020;127(10):1427–1429. doi:10.1016/j.ophtha.2020.06.031
   Web of Science ®Google Scholar
• Bostanci Ceran B, Karakoc A, Taciroglu E. Airborne pathogen projection during ophthalmic examination. Graefe’s Arch Clin Exp Ophthalmol. 2020;258(10):2275–2282. doi:10.1007/s00417-020-04815-4
   Web of Science ®Google Scholar
• van Doremalen N, Bushmaker T, Morris DH, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med. 2020;382(16):1564–1567. doi:10.1056/NEJMc2004973
   PubMed Web of Science ®Google Scholar
• Deng W, Bao L, Gao H, et al. Ocular conjunctival inoculation of SARS-CoV-2 can cause mild COVID-19 in rhesus macaques. Nat Commun. 2020;11(1):4400. doi:10.1038/s41467-020-18149-6
   PubMed Web of Science ®Google Scholar
• Paulsen F, Thale A, Kohla G, et al. Functional anatomy of human lacrimal duct epithelium. Anat Embryol (Berl). 1998;198(1):1–12. doi:10.1007/s004290050160
   Google Scholar
• Hu Y, Chen T, Liu M, et al. Positive detection of SARS-CoV-2 combined HSV1 and HHV6B virus nucleic acid in tear and conjunctival secretions of a non-conjunctivitis COVID-19 patient with obstruction of common lacrimal duct. Acta Ophthalmol. 2020;98:859–863. doi:10.1111/aos.14456
   PubMed Web of Science ®Google Scholar
• Valente P, Iarossi G, Federici M, et al. Ocular manifestations and viral shedding in tears of pediatric patients with coronavirus disease 2019: a preliminary report. J AAPOS. 2020;24(4):212–215. doi:10.1016/j.jaapos.2020.05.002
   PubMed Web of Science ®Google Scholar
• Casagrande M, Fitzek A, Puschel K, et al. Detection of SARS-CoV-2 in human retinal biopsies of deceased COVID-19 patients. Ocul Immunol Inflamm. 2020;28(5):721–725. doi:10.1080/09273948.2020.1770301
   PubMed Web of Science ®Google Scholar
• Chen X, Yu H, Mei T, et al. SARS-CoV-2 on the ocular surface: is it truly a novel transmission route? Br J Ophthalmol. 2020;bjophthalmol-2020-316263. Doi:10.1136/bjophthalmol-2020-316263
   Web of Science ®Google Scholar
• de Figueiredo CS, Raony Í, Giestal-de-Araujo E. SARS-CoV-2 targeting the retina: host-virus interaction and possible mechanisms of viral tropism. Ocul Immunol Inflamm. 2020;1–4.
   Web of Science ®Google Scholar
• Coroneo MT. The eye as the discrete but defensible portal of coronavirus infection. review. Ocul Surf. 2020. doi:10.1016/j.jtos.2020.05.011
   Web of Science ®Google Scholar
• Barnett BP, Wahlin K, Krawczyk M, et al. Potential of ocular transmission of SARS-CoV-2: a review. Vision (Basel, Switzerland). 2020;4(3). doi:10.3390/vision4030040.
   Google Scholar
• Güemes-Villahoz N, Burgos-Blasco B, Vidal-Villegas B, et al. Novel insights into the transmission of SARS-CoV-2 through the ocular surface and its detection in tears and conjunctival secretions: a review. Adv Ther. 2020;37(10):4086–4095. doi:10.1007/s12325-020-01442-7
   PubMed Web of Science ®Google Scholar
• Arora R, Goel R, Kumar S, et al. Evaluation of SARS-CoV-2 in tears of patients with moderate to severe COVID-19. Ophthalmology. 2020. doi:10.1016/j.ophtha.2020.08.029
   Web of Science ®Google Scholar
• Atum M, Boz AAE, Cakir B, et al. Evaluation of conjunctival swab PCR results in patients with SARS-CoV-2 infection. Ocul Immunol Inflamm. 2020;28(5):745–748. doi:10.1080/09273948.2020.1775261
   PubMed Web of Science ®Google Scholar
• Deng C, Yang Y, Chen H, et al. Low risk of SARS-CoV-2 transmission through the ocular surface. Acta Ophthalmol. 2020;98(7):e926–e927. doi:10.1111/aos.14471
   Web of Science ®Google Scholar
• Guemes-Villahoz N, Burgos-Blasco B, Arribi-Vilela A, et al. Detecting SARS-CoV-2 RNA in conjunctival secretions: is it a valuable diagnostic method of COVID-19? J Med Virol. 2020.
   Web of Science ®Google Scholar
• Karimi S, Arabi A, Shahraki T, Safi S. Detection of severe acute respiratory syndrome Coronavirus-2 in the tears of patients with Coronavirus disease 2019. Eye (London, England). 2020;34(7):1220–1223. doi:10.1038/s41433-020-0965-2
   PubMed Web of Science ®Google Scholar
• Kaya H, Caliskan A, Okul M, Sari T, Akbudak IH. Detection of SARS-CoV-2 in the tears and conjunctival secretions of Coronavirus disease 2019 patients. Article. J Infect Dev Ctries. 2020;14(9):977–981. doi:10.3855/jidc.13224
   PubMed Web of Science ®Google Scholar
• Kumar K, Prakash AA, Gangasagara SB, et al. Presence of viral RNA of SARS-CoV-2 in conjunctival swab specimens of COVID-19 patients. Indian J Ophthalmol. 2020;68(6):1015–1017. doi:10.4103/ijo.IJO_1287_20
   PubMed Web of Science ®Google Scholar
• Li X, Wang M, Chen C, Yang A, Jin W. Ophthalmologists’ strategy for the prevention and control of coronavirus pneumonia with conjunctivitis or with conjunctivitis as the first symptom. Article. Zhonghua Shiyan Yanke Zazhi. 2020;38(3):276–280.
   Google Scholar
• Li X, Chan JF, Li KK, et al. Detection of SARS-CoV-2 in conjunctival secretions from patients without ocular symptoms. Infection. 2020. doi:10.1007/s15010-020-01524-2
   Web of Science ®Google Scholar
• Liang L, Wu P. There may be virus in conjunctival secretion of patients with COVID-19. Acta Ophthalmol. 2020;98(3):223. doi:10.1111/aos.14413
   PubMed Web of Science ®Google Scholar
• Mahmoud H, Ammar H, El Rashidy A, Ali AH, Hefny HM, Mounir A. Assessment of coronavirus in the conjunctival tears and secretions in patients with SARS-CoV-2 infection in Sohag Province, Egypt. Clin Ophthalmol (Auckland, NZ). 2020;14:2701–2708. doi:10.2147/OPTH.S270006
   Web of Science ®Google Scholar
• Wu P, Duan F, Luo C, et al. Characteristics of ocular findings of patients with Coronavirus disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol. 2020;138(5):575–578. doi:10.1001/jamaophthalmol.2020.1291
   PubMed Web of Science ®Google Scholar
• Xia J, Tong J, Liu M, Shen Y, Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol. 2020;92(6):589–594. doi:10.1002/jmv.25725
   PubMed Web of Science ®Google Scholar
• Xie HT, Jiang SY, Xu KK, et al. SARS-CoV-2 in the ocular surface of COVID-19 patients. Eye Vision (London, England). 2020;7:23. doi:10.1186/s40662-020-00189-0
   PubMed Web of Science ®Google Scholar
• Zhou Y, Duan C, Zeng Y, et al. Ocular findings and proportion with conjunctival SARS-COV-2 in COVID-19 patients. Ophthalmology. 2020;127(7):982–983. doi:10.1016/j.ophtha.2020.04.028
   PubMed Web of Science ®Google Scholar
• Dutescu RM, Banasik P, Schildgen O, Schrage N, Uthoff D. Detection of Coronavirus in tear samples of hospitalized patients with confirmed SARS-CoV-2 from oropharyngeal swabs. Cornea. 2020;Publish Ahead of Print. doi:10.1097/ICO.0000000000002562
   Web of Science ®Google Scholar
• Fang Z, Zhang Y, Hang C, Ai J, Li S, Zhang W. Comparisons of viral shedding time of SARS-CoV-2 of different samples in ICU and non-ICU patients. Letter. J Infect. 2020;81(1):147–178. doi:10.1016/j.jinf.2020.03.013
   Web of Science ®Google Scholar
• Huang Y, Chen S, Yang Z, et al. SARS-CoV-2 viral load in clinical samples from critically ill patients. Am J Respir Crit Care Med. 2020;201(11):1435–1438. doi:10.1164/rccm.202003-0572LE
   PubMed Web of Science ®Google Scholar